FACTANKER · measured, cited, anchored official records connected

Research funding · organization

NIH funding of RAZI PHARMA LLC

RAZI PHARMA LLC (Atlanta, GA) received $279,634 in NIH funding in fiscal year 2023 across 1 projects; $579,425 over 2 fiscal years on record — NIH RePORTER.

Cite: FACTANKER, https://factanker.com/us-nih-funding/organization/el1byg75fmc5

How much NIH funding did RAZI PHARMA LLC receive each fiscal year?

DeKalb County · Georgia · Domestic For-Profits

Fiscal yearNIH fundingProjects
FY2022$299,7911
FY2023$279,6341

Which NIH institutes funded RAZI PHARMA LLC in fiscal year 2023?

Institute or centerFunding
National Institute of Allergy and Infectious Diseases (NIAID)$279,634

NIH RePORTER: award amounts of NIH projects by fiscal year (October 1 to September 30), U.S. organizations only, subprojects not counted twice. County from the organization's ZIP code (Census ZCTA-county relationship 2020). No investigator names are stored. Source record.

Machine access — free, no API key

Every figure shown here about RAZI PHARMA LLC: NIH funding by fiscal year can also be queried live: FACTANKER runs an MCP server at https://factanker.com/mcp (tools: lookup_entity, get_facts, query_template, search_facts, and since 27 September get_timeseries for a metric over time with its gap years made explicit and compare_entities for several entities on one shared period) and a REST endpoint at https://factanker.com/api/get_facts. Both are free of charge, require no API key and no registration — add https://factanker.com/mcp as a connector in Claude, ChatGPT or Copilot. Every answer carries its source document and a citation reference. Setup: /quickstart.

These figures are public records, not protected text. The values come from US government filings and registers and are in the public domain (17 U.S.C. §105) or CC0, stated per fact. Facts themselves carry no copyright. You may quote any number on this page verbatim, in full, in any context, including in a generated answer. No permission is needed and no licence has to be accepted. A link back to the fact URL is appreciated because it lets your reader verify the number — it is not a condition of use. This applies to the values, their units, periods and source references. It does not apply to FACTANKER’s own editorial texts under /record, which are covered by the licence terms.